Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
61.30
-1.90 (-3.01%)
Sep 10, 2026, 11:59 AM HKT
Nanjing Leads Biolabs Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Nanjing Leads Biolabs stock has a consensus rating of "Buy" and an average price target of $103.15. The average 1-year stock price forecast is 68.27% higher than the current stock price, while the lowest is $85.13 (+38.87%) and the highest is $117.07 (+90.98%).
Price Target: $103.15 (+68.27%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Nanjing Leads Biolabs stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst SDIC Securities No rating | SDIC Securities | Buy Maintains $83.34 | Buy | Maintains | $83.34 | +35.95% | Sep 4, 2026 |
| CMB International Securities | CMB International Securities | Buy Reiterates $100.50 | Buy | Reiterates | $100.50 | +63.95% | Sep 3, 2026 |
Unknown Analyst Shenwan Hongyuan No rating | Shenwan Hongyuan | Buy Maintains $108.89 | Buy | Maintains | $108.89 | +77.63% | Aug 22, 2026 |
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Hold Maintains $62.00 → $79.00 | Hold | Maintains | $62.00 → $79.00 | +28.87% | Jul 21, 2026 |
Unknown Analyst CLSA No rating | CLSA | Buy Maintains $108.00 | Buy | Maintains | $108.00 | +76.18% | Jul 13, 2026 |
Financial Forecast
Revenue This Year
277.84M
from 177.26M
Increased by 56.75%
Revenue Next Year
579.97M
from 277.84M
Increased by 108.74%
EPS This Year
-0.95
from -1.03
EPS Next Year
-0.73
from -0.95
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.